Summary
Chlamydocin is a powerfulin vitro antitumoral agent, quickly inactivatedin vivo. A series of cyclic tetrapeptides related to chlamydocin or HC toxin and bearing a bioactive alkylating group on anε-amino-lysyl function have been examined for their antitumoral activity on L1210 and P388 murine leukemia cell lines. One analog was found to be potent at inhibiting L1210 cell proliferation and had a higher therapeutic index than the reference compound bis-β-chloroethylnitrosourea on thein vivo P388-induced leukemia model.
This is a preview of subscription content, log in via an institution to check access.
References
Alley MC, Scuderio DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1990) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 139–144
Closse A, Huguenin R (1974) Isolation and structure elucidation of chlamydocin. Helv Chim Acta 57: 533–545
Geran RI, Greenberg NH, McDonald MM, Schumacher AM, Abott BJ (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 3: 1–100
Staehelin H, Trippmacher A (1974) Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide. Eur J Cancer 10: 801–808
Walton JD, Earle ED, Staehelin H, Grieder A, Hiroda A, Suzuki A (1985) Reciprocal biological activity of the cyclic tetrapeptides chlamydocin and HC-toxin. Experientia 41: 348–350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernardi, E., Fauchère, JL., Atassi, G. et al. New antitumoral cyclopeptides. Amino Acids 6, 315–318 (1994). https://doi.org/10.1007/BF00813752
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00813752